Skip to main content
Clinical Trials/NL-OMON56731
NL-OMON56731Not yet recruitingNot Applicable

The effect of medical grade honey (L-Mesitran) for cervical intraepithelial neoplasia-II - Honey for CIN-II

Zuyderland Medisch Centrum0 sites60 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 64 (—)

Inclusion Criteria

  • In order to be eligible to participate in this study, a subject must meet all
  • of the following criteria:
  • - Women 18-40 years
  • - Primary CIN II confirmed histologically in the biopsy on colposcopic
  • examination
  • - Sufficiënt mastery of the Dutch language

Exclusion Criteria

  • A potential subject who meets any of the following criteria will be excluded
  • from participation in this study:
  • - Simultaneous abnormality in columnar epithelial cells (AIS).
  • - Hr-HPV negative cytology
  • - Immunosuppressant use/Autoimmune disease (HIV, CVID)
  • - History of cervical carcinoma or previous treatment for CIN (LLETZ or
  • - Pregnancy or the intention to become pregnant during the study period
  • - Legal incompetence
  • - Known allergies to honey

Investigators

Sponsor
Zuyderland Medisch Centrum

Similar Trials